Natalie T. Mills, MBBS, PhD

Discipline of Psychiatry, Adelaide Medical School, University of Adelaide, Australia

JCP
Celecoxib Augmentation of Vortioxetine for Cognition in MDD
Original Research

October 4, 2023

Anti-inflammatory augmentation of vortioxetine did not provide additional benefit in reducing cognitive symptoms of MDD.
Emma Sampson, Natalie T. Mills, Hikaru Hori, et al
JCP
Original Research

November 20, 2018

In your patients with MDD, cognitive deficits may have a greater impact than you realize. This study used the THINC-it assessment to determine the extent to which impaired cognition...
Matthew J. Knight, Célia Fourrier, Ellen Lyrtzis, et al

Celebrating
85 Years

Read the Journal of Clinical Psychiatry

Subscribe to read
more articles

Subscribe